• 대한치과마취과학회:학술대회논문집
• /
• 2003.06a
• /
• pp.54-54
• /
• 2003

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.45 no.4
• /
• pp.186-191
• /
• 2019

Objectives: The aim of this study was to evaluate the journal category "oral surgery" in Scopus and in the Science Citation Index Expanded (SCIE). Materials and Methods: The Journal of Oral and Maxillofacial Surgery (JOMS), The Journal of the Korean Association of Oral and Maxillofacial Surgeons (JKAOMS), and The Journal of Prosthodontic Research (JPR) were selected from the Scopus list of journals as oral surgery journals. Maxillofacial Plastic and Reconstructive Surgery (MPRS) was selected from PubMed as a Scopus oral surgery title. From these titles, 10 recently published articles were collected and used for reference analysis. Results: The percentage of citations from oral surgery journals was 26.7%, 24.5%, and 40.1% for JKAOMS, MPRS, and JOMS, respectively. In total, 1.1% of JPR's citations were from oral surgery journals and significantly fewer from other journals (P<0.001). The percentage of citations from dentistry journals excluding oral surgery journals was 11.9%, 34.4%, and 15.8% for JKAOMS, MPRS, and JOMS, respectively. For JPR, 80.6% of citations were from dentistry journals and significantly more were from other journals (P<0.001). Conclusion: Selected samples revealed that JPR is incorrectly classified as an oral surgery journal in Scopus. In addition, the scientific interaction among JKAOMS, MPRS, and JOMS was different to JPR in the reference analysis.

• Journal of Periodontal and Implant Science
• /
• v.49 no.1
• /
• pp.58-58
• /
• 2019

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1998.06a
• /
• pp.27-27
• /
• 1998

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1997.06a
• /
• pp.54-54
• /
• 1997

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1998.06a
• /
• pp.43-43
• /
• 1998

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.47 no.5
• /
• pp.341-350
• /
• 2021

Dexamethasone has been used in oral and maxillofacial surgery for postoperative pain, swelling, and trismus following third molar surgeries. It is a potent and powerful drug that can alleviate the aforementioned postoperative sequelae. Dexamethasone is responsible for inhibiting the release of inflammatory mediators in the inflammation process to improve patient quality of life after surgical intervention. There are several available routes of administering dexamethasone. This article will help determine the suggested routes of administration, dosage, parameters, and dexamethasone timing for third molar surgeries.

• Proceedings of The Korean Cleft Lip And Palate Association
• /
• 1998.06a
• /
• pp.41-41
• /
• 1998

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.42 no.3
• /
• pp.162-165
• /
• 2016

We report a case of a morbidly obese man with an aortic aneurysm, in whom dental surgery was performed before elective cardiac surgery. His aortic aneurysm required emergency surgery. However, because of his morbid obesity, elective cardiac surgery was planned. Considering the high risk of infective endocarditis, dental surgery was required. Our patient was at a high risk of aortic rupture caused by hypertension and breathing difficulty in the supine position. Dexmedetomidine (DEX) is an anti-anxiety, sedative, and analgesic medicine that can stabilize circulatory dynamics and minimize blood pressure fluctuations. We administered intravenous DEX for sedation of the patient in Fowler's position. In conclusion, our understanding of the risk factors of DEX enabled us to perform safe invasive oral treatment.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• v.43 no.3
• /
• pp.212-212
• /
• 2017